Location History:
- Saint Germain en Laye, FR (2007 - 2010)
- Saint-German-en-Laye, FR (2016)
Company Filing History:
Years Active: 2007-2016
Title: The Innovations of Jean-Claude Mongrenier
Introduction
Jean-Claude Mongrenier is a notable inventor based in Saint Germain-en-Laye, France. He has made significant contributions to the field of technology, particularly in methods related to container qualification and blood bag monitoring. With a total of four patents to his name, Mongrenier's work reflects a commitment to advancing medical technology and improving patient care.
Latest Patents
Mongrenier's latest patents include a "Container qualification method, associated storage enclosure" and a "Method for determining and monitoring ageing of blood bags." The first patent outlines a qualification method for a container equipped with an RFID tag, which involves measuring temperature within a storage enclosure using a sensor and an RFID reader. The second patent focuses on determining the ageing index of blood bags to assess their suitability for transfusion. This method utilizes a silicon chip with a loop antenna connected to an electronic communication device, allowing for regular calculations of the ageing index at blood transfusion centers.
Career Highlights
Throughout his career, Mongrenier has worked with various companies, including Biolog, Inc. and Biolog S.A. His innovative approaches have led to advancements in medical technology, particularly in the management and storage of blood products. His patents demonstrate a deep understanding of both technology and healthcare needs.
Collaborations
Mongrenier has collaborated with notable individuals in his field, including Antoine De Gaulle and François Dussaux. These partnerships have likely contributed to the development and refinement of his innovative ideas.
Conclusion
Jean-Claude Mongrenier's contributions to technology and healthcare through his patents highlight his role as a significant inventor. His work continues to impact the medical field, particularly in improving the safety and efficacy of blood transfusions.